ChartRow logo
IBB
iShares Biotechnology ETFETF · Themes
$202.93+0.14%
as of market close, Sep 11, 2026
☾ AH
PeersSPYQQQNVDAAAPLMSFTAMZN

iShares Biotechnology ETF returns by year

Through September 11, 2026

iShares Biotechnology ETF returns by year (2002–2026)#

iShares Biotechnology ETF annual returns by year
YearTotal return
2026YTD
+20.3%
2025
+28.0%
2024
-2.4%
2023
+3.8%
2022
-13.7%
2021
+1.0%
2020
+26.0%
2019
+25.2%
2018
-9.5%
2017
+21.1%
2016
-21.4%
2015
+11.6%
2014
+33.8%
2013
+65.5%
2012
+31.5%
2011
+11.7%
2010
+14.2%
2009
+15.2%
2008
-12.3%
2007
+4.5%
2006
+0.7%
2005
+2.4%
2004
+4.8%
2003
+45.8%
2002
-45.8%
Annualized
+7.6%
2002–2026
Average year
+10.1%
24 full years
Best year
+65.5%
2013
Worst year
-45.8%
2002
Positive years
18/24
75% up

Total return by period#

Annual

Methodology#

Returns are total returns (dividends reinvested), computed from IBB's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. Past performance does not predict future returns; not investment advice.

FAQ#

What is iShares Biotechnology ETF's average annual return?
Since 2002, iShares Biotechnology ETF (IBB) has returned about 7.6% a year (the compound annual growth rate) and an average calendar-year return of 10.1%.
What were iShares Biotechnology ETF's best and worst years?
Over 2002–2026, the best year was 2013 (+65.5%) and the worst was 2002 (-45.8%).
How often is iShares Biotechnology ETF up in a year?
18 of the 24 full years since 2002 were positive — about 75% of the time.

More on iShares Biotechnology ETF